4D MOLECULAR THERAPEUTICS
4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
4D MOLECULAR THERAPEUTICS
Industry:
Biotechnology Genetics
Founded:
2013-01-01
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.4dmoleculartherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(510) 505-2680
Total Funding:
175 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
BioMarin Pharmaceutical
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Purigen Biosystems
Purigen Biosystems' innovative products offer a truly transformative automated solution for DNA and RNA purification.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Advisor
2018-02-01
Board_member
2020-08-01
Current Employees Featured
Peter Francis Chief Scientific Officer & Therapeutic Area Head, Ophthalmology @ 4D Molecular Therapeutics
Chief Scientific Officer & Therapeutic Area Head, Ophthalmology
2020-02-01
Fred Kamal Chief Operating Officer & Chief Technical Officer @ 4D Molecular Therapeutics
Chief Operating Officer & Chief Technical Officer
2020-02-01
Theresa Janke Chief Strategic Officer & Co-founder @ 4D Molecular Therapeutics
Chief Strategic Officer & Co-founder
David Kirn Co-Founder, President & CEO @ 4D Molecular Therapeutics
Co-Founder, President & CEO
2013-04-01
Founder
Stock Details
Investors List
Longevity Vision Fund
Longevity Vision Fund investment in Series C - 4D Molecular Therapeutics
MiraeAsset Financial Group
MiraeAsset Financial Group investment in Series C - 4D Molecular Therapeutics
BVF Partners
BVF Partners investment in Series C - 4D Molecular Therapeutics
Pappas Capital
Pappas Capital investment in Series C - 4D Molecular Therapeutics
Chiesi Ventures
Chiesi Ventures investment in Series C - 4D Molecular Therapeutics
Viking Global Investors
Viking Global Investors investment in Series C - 4D Molecular Therapeutics
QUAD Investment Management
QUAD Investment Management investment in Series C - 4D Molecular Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series C - 4D Molecular Therapeutics
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Series C - 4D Molecular Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - 4D Molecular Therapeutics
Official Site Inspections
http://www.4dmoleculartherapeutics.com Semrush global rank: 4.03 M Semrush visits lastest month: 3.04 K
Unable to get host informations!!!
More informations about "4D Molecular Therapeutics"
About | 4DMT - 4D Molecular Therapeutics
4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market diseases.See details»
4D Molecular Therapeutics - LinkedIn
4D Molecular Therapeutics | 17,395 followers on LinkedIn. Powering the Future of Genetic Medicines | 4DMT is a clinical stage biopharma company inventing and developing innovative products to ...See details»
Investors & Media | 4D Molecular Therapeutics
4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. 4DMT is striving to unlock the full potential of genetic medicines …See details»
4D Molecular Therapeutics - Crunchbase Company …
4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes transformative gene therapeutic products for …See details»
4D Molecular Therapeutics Inc Company Profile - Overview
Website 4dmoleculartherapeutics.com Telephone 1 510 5052680. No of Employees 201. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange FDMT (NASD) Revenue (2023) …See details»
4D Molecular Therapeutics - Craft
Oct 29, 2024 4D Molecular Therapeutics has 5 employees at their 1 location and $37 k in annual revenue in FY 2024. See insights on 4D Molecular Therapeutics including office locations, …See details»
4D Molecular Therapeutics - VentureRadar
"4DMT is a gene therapy company with a transformative discovery platform—Therapeutic Vector Evolution—that enables our “disease first” approach to product discovery and development, …See details»
4D Molecular Therapeutics Management Team | Org Chart
4dmoleculartherapeutics.com; 5+ 408200XXXX; 608861XXXX; 310825XXXX; 925730XXXX; 925353XXXX; 650307XXXX; Carrie Murray Vice President, Medical Affairs at 4D Molecular …See details»
4D Molecular Therapeutics, Inc. (4D Molecular Therapeutics, Inc.)
EMERYVILLE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company …See details»
4D Molecular Therapeutics
4dmoleculartherapeutics.com. linkedin.com . job board . Business: Gene Therapy. Drug notes: 4D-150 Clin1/Clin2 wet AMD, Clin0 DME; 4D-125 Clin1/Clin2 XLRP; 4D-110 Clin1/Clin2 …See details»
Release Details - 4D Molecular Therapeutics
EMERYVILLE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing the power of directed …See details»
4DMT to Participate in Upcoming Investor Conferences
EMERYVILLE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company …See details»
4DMT- Gene therapy company that customizes AAV vectors to …
Oct 19, 2021 4D Molecular Therapeutics: https://www.4dmoleculartherapeutics.com - Gene therapy was risky, but Dave took the leap of faith counting on a few things- gene therapy …See details»
Release Details - ir.4dmoleculartherapeutics.com
Jan 10, 2025 Strategically focused pipeline optimizes resource allocation to progress two product candidates with strongest clinical proof of concept: 4D-150 for wet AMD and DME and …See details»
Chapters and Groups - Mended Hearts
Support Group Meetings: The most common activity of chapters and groups is support group meetings, either in-person (where possible), online, or a hybrid. These meetings allow patients …See details»
Gumax | Non-Profit Organization In Woodbridge
Gumax is a dedicated non-profit organization in Woodbridge, committed to uplifting our community through various impactful initiatives and programs. Skip to content. f; t; g; i; y; 609 …See details»
Release Details - 4D Molecular Therapeutics
Jan 4, 2024 Poised for multiple meaningful catalysts in 2024 driven by strong clinical progress across large market programs in wet age-related macular degeneration (wet AMD), diabetic …See details»
Lynn Steinberg PhD LMFT
Dr. Steinberg consults with families, couples, groups and individuals. She specializes in working with alienated parents and alienated children.See details»
4DMT Reports Full Year 2024 Financial Results, Operational …
Dec 31, 2024 Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across …See details»
Medical Device Contract Manufacturing – Sterling Industries
We start by understanding your design ideas, and offer design engineering, as well as Design for Manufacturing & Assembly (DFMA) expertise.We source materials and negotiate with trusted …See details»